To meet market demands, improve management and take advantage of business synergy, Dexco improves its governance model with the creation of Advisory Committees highlighted below, which aim to assist the Executive Board.
Analyzes Dexco’s competition and competitiveness, in addition to monitoring and approving the Company’s investments in permanent assets. It is formed by a coordinator and five members.
This committee assesses and monitors the risks involved in the Company’s operations and activities, being coordinated by the internal audit, risk management and Compliance management and composed of the members of the Executive Board.
The Ethics Committee ensures compliance with the Company’s Code of Conduct, evaluates and decides on critical behavior in violation of the Code and other internal rules of the Company, as well as the Legislation, deciding on the possible application of disciplinary measures. It is composed of the Executive Committee, internal audit management, risk management and compliance, legal management and human and organizational development.
Data Protection and Privacy Commission
Its objective is to monitor data management in the Company in relation to the General Data Protection Law, as well as to resolve on matters related to it. It reports its activities to the Executive Committee and is made up of the internal audit, risk management and compliance, information and data security, Shared Services Center (CSC) and legal departments.
Evaluates ESG aspects and practices, debates and advises on topics such as the analysis of new market demands on the Company’s role in social actions, the environment and governance. It consists of an ESG manager and five members.
Disclosure and Trading Commission
Advises the Investor Relations Officer, reviews and approves the information disclosed to the market, previously analyzes the content of the materials for meetings with investors and analysts (road shows) and public presentations that contain information about the Company; analyzes the content of responses referring to official inquiries from regulatory and self-regulatory bodies, thus helping to comply with the Company’s Policy for Trading Securities and Disclosure of Relevant Act or Fact. It is made up of a member of the Board of Directors, in addition to the Chief Executive Officer, Investor Relations Officer, and the legal and ESG managers.